Advertisement
Research paper| Volume 42, ISSUE 2-3, P141-160, April 1982

Renin as a risk factor for atherogenesis

Part 3. Effects of hypercholesterolemia, hyporeninemia and one-kidney-one-clip hypertension in the rabbit
  • Merrill L. Overturf
    Correspondence
    Reprint requests to: Merrill L. Overturf, Ph.D., The University of Texas Medical School, Internal Medicine/Hypertension, Room 1278 MSMB, P.O. Box 20708, Houston, TX 77025, U.S.A.
    Affiliations
    Department of Medicine, The University of Texas Medical School, and the Department of Pathology, Baylor College of Medicine, Houston, TX U.S.A.
    Search for articles by this author
  • Harley D. Sybers
    Affiliations
    Department of Medicine, The University of Texas Medical School, and the Department of Pathology, Baylor College of Medicine, Houston, TX U.S.A.
    Search for articles by this author
  • Robert E. Druilhet
    Affiliations
    Department of Medicine, The University of Texas Medical School, and the Department of Pathology, Baylor College of Medicine, Houston, TX U.S.A.
    Search for articles by this author
  • Walter M. Kirkendall
    Affiliations
    Department of Medicine, The University of Texas Medical School, and the Department of Pathology, Baylor College of Medicine, Houston, TX U.S.A.
    Search for articles by this author
DOI:https://doi.org/10.1016/0021-9150(82)90146-0
Renin as a risk factor for atherogenesis
Previous ArticleEffect of clinofibrate, a new hypelipidemic agent, on biliary and serum lipids in patients with hyperlipidemia
Next ArticleApoprotein S, a family of human serum lipoprotein polypeptides
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The purpose of this study was to test the hypothesis that plasma renin activity (PRA) is a risk factor for cardiovascular disease. Four groups of New Zealand rabbits were used to study the effects of PRA and hypertension on atherogenesis. Control groups were fed normal rabbit chow (Group I), or normal chow supplemented with 0.25% cholesterol (Group III) Group II animals were fed normal chow, had a clip placed around the left renal artery and were contralaterally nephrectomized (one-kidney-one-clip, 1K-1C). The renal arteries and kidneys of Group IV animals, which were fed a cholesterol diet, were manipulated similarly. Blood pressure and blood chemistry measurements were performed periodically over a 7-month period. The blood pressure was unaffected by either diet; however, PRA and aldosterone levels were greatly reduced in the 1 K-1 C groups (Groups II and IV). No atheroma were observed in any of the animals consuming the normal diet (Groups I and II) despite sharply elevated blood pressure in the Group II animals. Medial hypertrophy of small muscular arteries was observed in several Group II animals. All of the animals fed the atherogenic diet showed extensive aortic atheromata. There was, however, a significantly smaller lesion index for the normotensive cholesterol-fed animals (Group III) than those with increased blood pressure (Group IV). Likewise, microscopic evaluation of the aorta, coronary arteries, renal arteries, and kidneys mirrored this difference in the vascular involvement between the animals of Groups III and IV. We conclude that neither relatively high nor low PRA levels affect the development of atherosclerosis or other cardiovascular lesions. However, hypertension with a concomitantly high cholesterol diet acts synergistically in exacerbating atherogenesis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Hypertension Detection and Follow-up Program Cooperative Group
        Five-year Findings of the Hypertension Detection and Follow-up Program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension.
        J. Amer. Med. Ass. 1979; 242: 2562
        • Kannel W.B.
        Hypertension, blood lipids, and cigarette smoking as co-risk factors for coronary heart disease.
        in: Perry H.M. Mild Hypertension to Treat or Not to Treat. Ann. N.Y. Acad. Sci.304. 1978: 128
        • Hypertension Detection and Follow-up Program Cooperative Group
        Five-year Findings of the Hypertension Detection and Follow-up Program: II. Mortality by race, sex and age.
        J. Amer. Med. Ass. 1979; 242: 2572
      4. Coronary Risk Handbook: Estimating the risk of coronary heart disease in daily practice. American Heart Association, 1973
        • Brunner H.R.
        • Buhler F.R.
        • Baer L.
        • Laragh J.H.
        Renin and aldosterone in etiology and prognosis of ‘essential’ hypertension.
        Circulation. 1971; 43 and 44: 121a
        • Laragh J.H.
        Renin as a predictor of hypertensive complications. Discussion.
        in: Perry H.M. Mild Hypertension to Treat or Not to Treat. Ann. N.Y. Acad. Sci.304. 1978: 165
        • Brunner H.R.
        • Laragh J.H.
        • Baer L.
        • Newton M.A.
        • Goodwin F.T.
        • Krakoff L.R.
        • Bard R.H.
        • Buhler F.R.
        Essential hypertension—Renin and aldosterone, heart attack and stroke.
        N. Engl. J. Med. 1972; 286: 441
        • Kirkendall W.M.
        • Hammond J.J.
        • Overturf M.L.
        Renin as a predictor of hypertensive complications.
        in: Perry H.M. Mild Hypertension to Treat or Not to Treat. Ann. N.Y. Acad. Sci.304. 1978: 147
        • Overturf M.L.
        • Aschenbrener C.
        • Druilhet R.E.
        • Kirkendall W.M.
        Renin as a risk factor for atherogenesis. I. Effects of hypercholesterolemia and two-kidney-one-clip hypertension in the rabbit.
        Atherosclerosis. 1981; 38: 97
        • Overturf M.L.
        • Sybers H.D.
        • Druilhet R.E.
        • Kirkendall W.M.
        Renin as risk factor in atherogenesis, Part 2 (Effects of hypercholesterolemia and hyporeninemia in the rabbit).
        Atherosclerosis. 1981; 40: 203
        • Kritchevsky D.
        • Tepper S.A.
        • Langan J.
        Cholesterol vehicle in experimental atherosclerosis, Part 4 (Influence of heated fat and fatty acids).
        J. Atheroscler. Res. 1962; 2: 115
        • Daniel P.M.
        • Prichard M.M.L.
        • Ward-McQuaid J.N.
        The renal circulation in experimental hypertension.
        Brit. J. Surg. 1954–1955; 42: 81
        • Wilson D.M.
        • Romero J.C.
        • Strong C.G.
        • Lee K.E.
        • Schryver S.M.
        Indirect blood pressure measurements in the rabbit—Correlations with direct aortic and ear pressures.
        J. Lab. Clin. Med. 1975; 86: 1032
        • Haber E.
        • Koerner T.
        • Page L.B.
        • Kliman B.
        • Purnode A.
        Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.
        J. Clin. Endocrinol. Metab. 1969; 29: 1349
        • Menard J.
        • Catt K.J.
        Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I.
        Endocrinology. 1972; 90: 422
        • Printz M.P.
        • Printz J.M.
        • Dworschack R.T.
        Human angiotensinogen.
        J. Biol. Chem. 1977; 252: 1654
        • Bevan R.D.
        • Van Marthens E.
        • Bevan J.D.
        Hyperplasia of vascular smooth muscle in experimental hypertension in the rabbit.
        Circ. Res. 1976; 24: 58
        • Naito H.K.
        • Wada M.
        • Ehrhart L.A.
        • Lewis L.A.
        Polyacrylamide-gel disc-electrophoresis as a screening procedure for serum lipoprotein abnormalities.
        Clin. Chem. 1973; 19: 228
        • Muniz N.
        Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel.
        Clin. Chem. 1977; 23: 1826
        • Trinder P.
        Determination of glucose in blood using glucose with an alternative oxygen acceptor.
        Ann. Clin. Biochem. 1969; 6: 24
        • Allain C.C.
        • Poon L.S.
        • Chan C.S.G.
        • Richmond W.
        • Fu P.C.
        Enzymatic determination of total serum cholesterol.
        Clin. Chem. 1974; 20: 470
        • Warnick G.R.
        • Albers J.J.
        A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.
        J. Lipid Res. 1978; 19: 65
        • Nowaczynski W.C.
        • Sasaki C.
        • Genest J.
        Radioimmunoassay for aldosterone and normal values under various physiological conditions.
        J. Steroid Biochem. 1974; 5: 123
        • Bradford M.M.
        A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
        Anal. Biochem. 1976; 72: 248
        • Bedrossian C.W.M.
        • Anderson A.E.
        • Foraker A.G.
        Comparison of methods for quantitating bronchial morphology.
        Thorax. 1971; 26: 406
        • Fisher E.R.
        • Creed D.L.
        • Baird W.F.
        Effect of renal hypertension on cholesterol atherosclerosis in the rabbit.
        Lab. Invest. 1958; 7: 231
        • Newman H.A.I.
        • Zilversmit D.B.
        Quantitative aspects of cholesterol flux in rabbit atheromatous lesions.
        J. Biol. Chem. 1972; 237: 2078
        • Kritchevsky D.
        Animal models for atherosclerosis research.
        in: Handbook of Experimental Pharmacology. Vol. 41. Springer-Verlag, Berlin, New York1975: 215
        • Kurihara H.
        • Gregory A.
        • Dewailly P.
        • Boucher R.
        • Genest J.
        Effects of changes in sodium balance and of experimental renal hypertension on plasma angiotensin I converting enzyme activity of rabbits.
        Tohoku J. Exp. Med. 1973; 109: 19
        • Fujii J.
        • Seki A.
        • Kuramochi M.
        Contrastive profiles in two types of renovascular hypertension in rabbits.
        Jap. Heart J. 1973; 14: 445
        • Peart W.S.
        • Robertson J.I.S.
        • Grahame-Smith D.G.
        Examination of the relationship of renin release to hypertension produced in the rabbit by renal-artery constriction.
        Circ. Res. 1961; 9: 1171
        • Romero J.C.
        • Strong C.G.
        The effect of indomethacin blockade of prostaglandin synthesis on blood pressure of normal rabbits and rabbits with renovascular hypertension.
        Circ. Res. 1977; 40: 35
        • Johnson J.A.
        • Davis J.O.
        • Braverman B.
        Role of angiotensin II in experimental renal hypertension in the rabbit.
        Amer. J. Physiol. 1975; 228: 11
        • Fujii J.
        • Yazaki Y.
        Renin, electrolytes and water intake in two types of experimental renal hypertension.
        Amer. J. Physiol. 1972; 222: 979
        • Kramsch D.M.
        • Aspen A.J.
        • Apstein C.S.
        Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum.
        J. Clin. Invest. 1980; 65: 967
        • Giese J.
        Renin, angiotensin and hypertensive vascular damage—A review.
        Amer. J. Med. 1973; 55: 315

      Article info

      Publication history

      Accepted: August 12, 1981
      Received: March 19, 1981

      Footnotes

      ☆This work was supported in part by N.I.H., Heart, Lung and Blood Institute Grant HL-20189 and The Lillian and Charles Duncan Research Grant for Atherosclerosis Research.

      Identification

      DOI: https://doi.org/10.1016/0021-9150(82)90146-0

      Copyright

      © 1982 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX